Campbell & Co Investment Adviser’s CareDx CDNA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,197	Closed	-$234K	–	1164
2025 Q1	$234K	Sell	13,197 -27,134	-67%	-$584K	0.02%	907
2024 Q4	$863K	Buy	+40,331	New	+$981K	0.07%	449
2024 Q3	–	Sell	-22,384	Closed	-$348K	–	1117
2024 Q2	$348K	Buy	+22,384	New	+$271K	0.03%	781
2023 Q1	–	Sell	-16,645	Closed	-$190K	–	827
2022 Q4	$190K	Buy	+16,645	New	+$247K	0.05%	699
2022 Q1	–	Sell	-6,300	Closed	-$287K	–	711
2021 Q4	$287K	Buy	+6,300	New	+$329K	0.1%	377

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Campbell & Co Investment Adviser's CDNA Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of CareDx (CDNA) in Q2 2025, closing a stake of 13,197 shares — an estimated $234K sold.

Campbell & Co Investment Adviser first reported a position in CDNA in Q4 2021 and held it in 5 quarters. The position peaked at $863K in Q4 2024. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

Campbell & Co Investment Adviser reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 13,197 CareDx shares in Q2 2025, an estimated $234K.
Campbell & Co Investment Adviser first reported a position in CareDx in Q4 2021 and held it in 5 quarters.
Campbell & Co Investment Adviser's CareDx position peaked at $863K in Q4 2024.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.